6505-01-564-8033 ( 918377 , DIFFERIN CRM 0.1PCT 30G , 9318637087914 , 617547 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-564-8033 | 6505 | 015648033 | ADAPALENE CREAM | 6745 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CSGS | ADMINISTRATION | TOPICAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 45.000 GRAMS |
| CQCT | PRIMARY CONTAINER TYPE | TUBE |
| FEAT | SPECIAL FEATURES | TOPICAL ACNE TREATMENT CREAM, NOT FOR ORAL, INTRAVAGINAL OR OPTHALMIC USE; MAY CAUSE LOCAL IRRITATION, AVOID EYE CONTACT; QUICKLY ABSORBED; FOR SENSITIVE SKIN; PRESCRIPTION ONLY; CONTAINS ADAPALENE CREAM EMULSION; DO NOT USE ON SUNBURNED SKIN |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| 918377 | 0YDX3 | A | 2 | 5 | 5 | 9Z | |
| DIFFERIN CRM 0.1PCT 30G | 0YDX3 | A | 2 | 3 | 4 | 9Z | |
| 9318637087914 | Z0GL4 | A | 9 | 5 | 9 | ZA | |
| 617547 | Z7Y64 | A | 2 | 5 | 3 | ZA |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| 918377 | 0YDX3 | GALDERMA LABORATORIES INC | A | A |
| DIFFERIN CRM 0.1PCT 30G | 0YDX3 | GALDERMA LABORATORIES INC | A | A |
| 9318637087914 | Z0GL4 | GS1 AUSTRALIA PTY LTD | F | A |
| 617547 | Z7Y64 | SYMBION PHARMACY SERVICES | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | 0 | X | A | 1 | 06/27/2 | A | P | 3004909145 | 6745 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|